Pathology of the uterine corpus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Endometrial cancer is the fourth most common cancer in women in the United States. Endometrial carcinomas can be divided into two types based primarily on association with excess estrogen. Endometrioid adenocarcinoma is the prototypical type 1 endometrial carcinoma, well known for its association with excess estrogen. It is the most common uterine malignancy and usually occurs in postmenopausal women. Endometrial hyperplasia is widely recognized as a non-obligate precursor to endometrioid adenocarcinoma. Type 2 endometrial carcinomas are not associated with excess estrogen and include serous and clear cell carcinomas. Awide variety of other neoplasms occur in the uterus. More common entities include biphasic tumors like malignant mixed Mullerian tumors (MMMT) and mesenchymal malignancies such as endometrial stromal sarcoma and leiomyosarcomas. More rare uterine tumors include perivascular epithelioid cell tumor (PEComa), primitive neuroectodermal tumor (PNET), lymphoma, and gestational trophoblastic disease.

Original languageEnglish (US)
Title of host publicationHandbook of Gynecology
PublisherSpringer International Publishing
Pages1041-1058
Number of pages18
Volume2
ISBN (Electronic)9783319177984
ISBN (Print)9783319177977
DOIs
StatePublished - Aug 28 2017

Fingerprint

Endometrial Neoplasms
Pathology
Perivascular Epithelioid Cell Neoplasms
Endometrioid Carcinoma
Neoplasms
Estrogens
Endometrial Stromal Sarcoma
Malignant Mixed Tumor
Gestational Trophoblastic Disease
Endometrial Hyperplasia
Primitive Neuroectodermal Tumors
Leiomyosarcoma
Uterus
Lymphoma
Carcinoma

Keywords

  • Clear cell carcinoma
  • Endometrial hyperplasia
  • Endometrial intraepithelial neoplasia
  • Endometrial stromal sarcoma
  • Endometrioid adenocarcinoma
  • Gestational trophoblastic disease
  • Hydatidiform mole
  • Leiomyosarcoma
  • Malignant mixed mullerian tumor

ASJC Scopus subject areas

  • Medicine(all)
  • Health Professions(all)

Cite this

Hwang, H. (2017). Pathology of the uterine corpus. In Handbook of Gynecology (Vol. 2, pp. 1041-1058). Springer International Publishing. https://doi.org/10.1007/978-3-319-17798-4_63

Pathology of the uterine corpus. / Hwang, Helena.

Handbook of Gynecology. Vol. 2 Springer International Publishing, 2017. p. 1041-1058.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hwang, H 2017, Pathology of the uterine corpus. in Handbook of Gynecology. vol. 2, Springer International Publishing, pp. 1041-1058. https://doi.org/10.1007/978-3-319-17798-4_63
Hwang H. Pathology of the uterine corpus. In Handbook of Gynecology. Vol. 2. Springer International Publishing. 2017. p. 1041-1058 https://doi.org/10.1007/978-3-319-17798-4_63
Hwang, Helena. / Pathology of the uterine corpus. Handbook of Gynecology. Vol. 2 Springer International Publishing, 2017. pp. 1041-1058
@inbook{3bde3e21229840f99497bcbf96052eaf,
title = "Pathology of the uterine corpus",
abstract = "Endometrial cancer is the fourth most common cancer in women in the United States. Endometrial carcinomas can be divided into two types based primarily on association with excess estrogen. Endometrioid adenocarcinoma is the prototypical type 1 endometrial carcinoma, well known for its association with excess estrogen. It is the most common uterine malignancy and usually occurs in postmenopausal women. Endometrial hyperplasia is widely recognized as a non-obligate precursor to endometrioid adenocarcinoma. Type 2 endometrial carcinomas are not associated with excess estrogen and include serous and clear cell carcinomas. Awide variety of other neoplasms occur in the uterus. More common entities include biphasic tumors like malignant mixed Mullerian tumors (MMMT) and mesenchymal malignancies such as endometrial stromal sarcoma and leiomyosarcomas. More rare uterine tumors include perivascular epithelioid cell tumor (PEComa), primitive neuroectodermal tumor (PNET), lymphoma, and gestational trophoblastic disease.",
keywords = "Clear cell carcinoma, Endometrial hyperplasia, Endometrial intraepithelial neoplasia, Endometrial stromal sarcoma, Endometrioid adenocarcinoma, Gestational trophoblastic disease, Hydatidiform mole, Leiomyosarcoma, Malignant mixed mullerian tumor",
author = "Helena Hwang",
year = "2017",
month = "8",
day = "28",
doi = "10.1007/978-3-319-17798-4_63",
language = "English (US)",
isbn = "9783319177977",
volume = "2",
pages = "1041--1058",
booktitle = "Handbook of Gynecology",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Pathology of the uterine corpus

AU - Hwang, Helena

PY - 2017/8/28

Y1 - 2017/8/28

N2 - Endometrial cancer is the fourth most common cancer in women in the United States. Endometrial carcinomas can be divided into two types based primarily on association with excess estrogen. Endometrioid adenocarcinoma is the prototypical type 1 endometrial carcinoma, well known for its association with excess estrogen. It is the most common uterine malignancy and usually occurs in postmenopausal women. Endometrial hyperplasia is widely recognized as a non-obligate precursor to endometrioid adenocarcinoma. Type 2 endometrial carcinomas are not associated with excess estrogen and include serous and clear cell carcinomas. Awide variety of other neoplasms occur in the uterus. More common entities include biphasic tumors like malignant mixed Mullerian tumors (MMMT) and mesenchymal malignancies such as endometrial stromal sarcoma and leiomyosarcomas. More rare uterine tumors include perivascular epithelioid cell tumor (PEComa), primitive neuroectodermal tumor (PNET), lymphoma, and gestational trophoblastic disease.

AB - Endometrial cancer is the fourth most common cancer in women in the United States. Endometrial carcinomas can be divided into two types based primarily on association with excess estrogen. Endometrioid adenocarcinoma is the prototypical type 1 endometrial carcinoma, well known for its association with excess estrogen. It is the most common uterine malignancy and usually occurs in postmenopausal women. Endometrial hyperplasia is widely recognized as a non-obligate precursor to endometrioid adenocarcinoma. Type 2 endometrial carcinomas are not associated with excess estrogen and include serous and clear cell carcinomas. Awide variety of other neoplasms occur in the uterus. More common entities include biphasic tumors like malignant mixed Mullerian tumors (MMMT) and mesenchymal malignancies such as endometrial stromal sarcoma and leiomyosarcomas. More rare uterine tumors include perivascular epithelioid cell tumor (PEComa), primitive neuroectodermal tumor (PNET), lymphoma, and gestational trophoblastic disease.

KW - Clear cell carcinoma

KW - Endometrial hyperplasia

KW - Endometrial intraepithelial neoplasia

KW - Endometrial stromal sarcoma

KW - Endometrioid adenocarcinoma

KW - Gestational trophoblastic disease

KW - Hydatidiform mole

KW - Leiomyosarcoma

KW - Malignant mixed mullerian tumor

UR - http://www.scopus.com/inward/record.url?scp=85037854197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037854197&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-17798-4_63

DO - 10.1007/978-3-319-17798-4_63

M3 - Chapter

AN - SCOPUS:85037854197

SN - 9783319177977

VL - 2

SP - 1041

EP - 1058

BT - Handbook of Gynecology

PB - Springer International Publishing

ER -